Related references
Note: Only part of the references are listed.Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus
Marilia Brito Gomes et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
Mild gestational hyperglycaemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes
Carlos Antonio Negrato et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2008)
Gestational diabetes, pregnancy hypertension, and late vascular disease
Marshall W. Carpenter
DIABETES CARE (2007)
Clinical aspects of plasma platelet-activating factor-acetylhydrolase
Ken Karasawa
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases
Eugenio Cersosimo et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2006)
Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus
SM Heitritter et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors -: The Ludwigshafen risk and cardiovascular health study
K Winkler et al.
CIRCULATION (2005)
Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome
E Rizos et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
Inflammatory markers in women with a recent history of gestational diabetes mellitus
A Di Benedetto et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2005)
Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome
EO Talbott et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men
N Nakanishi et al.
DIABETES CARE (2004)
Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis
S Blankenberg et al.
JOURNAL OF LIPID RESEARCH (2003)
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study
DJ Freeman et al.
DIABETES (2002)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke
P Jousilahti et al.
STROKE (2000)
Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS)
A Festa et al.
CIRCULATION (2000)
Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase:: a potential new risk factor for coronary artery disease
MJ Caslake et al.
ATHEROSCLEROSIS (2000)
Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population
Y Yamada et al.
ATHEROSCLEROSIS (2000)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)